DP7‐C‐based systemic delivery was attempted with siRNA targeting STAT3, which has been demonstrated to be a key transduction and transcription factor in cancer progression.[33, 34] The anticancer effects of these compounds were characterized using a B16F10 cells and mouse lung metastasis melanoma mode (Figure 7a). This evidence concerns the gene STAT3 and melanoma.